ICU Medical Inc. (ICUI)
ICU Medical Statistics
Share Statistics
ICU Medical has 24.52M shares outstanding. The number of shares has increased by 1.42% in one year.
Shares Outstanding | 24.52M |
Shares Change (YoY) | 1.42% |
Shares Change (QoQ) | 0.24% |
Owned by Institutions (%) | 98.92% |
Shares Floating | 22.58M |
Failed to Deliver (FTD) Shares | 6 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 737.76K, so 3.01% of the outstanding shares have been sold short.
Short Interest | 737.76K |
Short % of Shares Out | 3.01% |
Short % of Float | 3.27% |
Short Ratio (days to cover) | 3.57 |
Valuation Ratios
The PE ratio is -32.16 and the forward PE ratio is 23.82. ICU Medical's PEG ratio is -0.11.
PE Ratio | -32.16 |
Forward PE | 23.82 |
PS Ratio | 1.59 |
Forward PS | 1.4 |
PB Ratio | 1.93 |
P/FCF Ratio | 30.36 |
PEG Ratio | -0.11 |
Enterprise Valuation
ICU Medical Inc. has an Enterprise Value (EV) of 3.85B.
EV / Earnings | -32.74 |
EV / Sales | 1.62 |
EV / EBITDA | 89.69 |
EV / EBIT | 89.69 |
EV / FCF | 30.91 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.81.
Current Ratio | 2.59 |
Quick Ratio | 1.54 |
Debt / Equity | 0.81 |
Total Debt / Capitalization | 44.61 |
Cash Flow / Debt | 0.13 |
Interest Coverage | 0.4 |
Financial Efficiency
Return on equity (ROE) is -0.06% and return on capital (ROIC) is 2.16%.
Return on Equity (ROE) | -0.06% |
Return on Assets (ROA) | -0.03% |
Return on Capital (ROIC) | 2.16% |
Revenue Per Employee | $158,803.07 |
Profits Per Employee | $-7,845.87 |
Employee Count | 15,000 |
Asset Turnover | 0.57 |
Inventory Turnover | 2.66 |
Taxes
Income Tax | 51.68M |
Effective Tax Rate | -0.78 |
Stock Price Statistics
The stock price has increased by 48.74% in the last 52 weeks. The beta is 0.74, so ICU Medical's price volatility has been higher than the market average.
Beta | 0.74 |
52-Week Price Change | 48.74% |
50-Day Moving Average | 155.59 |
200-Day Moving Average | 154.44 |
Relative Strength Index (RSI) | 51.01 |
Average Volume (20 Days) | 233.82K |
Income Statement
In the last 12 months, ICU Medical had revenue of 2.38B and earned -117.69M in profits. Earnings per share was -4.83.
Revenue | 2.38B |
Gross Profit | 824.78M |
Operating Income | 42.96M |
Net Income | -117.69M |
EBITDA | 42.96M |
EBIT | 42.96M |
Earnings Per Share (EPS) | -4.83 |
Balance Sheet
The company has 308.57M in cash and 1.58B in debt, giving a net cash position of -1.27B.
Cash & Cash Equivalents | 308.57M |
Total Debt | 1.58B |
Net Cash | -1.27B |
Retained Earnings | 690.16M |
Total Assets | 4.2B |
Working Capital | 885.8M |
Cash Flow
In the last 12 months, operating cash flow was 204.03M and capital expenditures -79.37M, giving a free cash flow of 124.66M.
Operating Cash Flow | 204.03M |
Capital Expenditures | -79.37M |
Free Cash Flow | 124.66M |
FCF Per Share | 5.11 |
Margins
Gross margin is 34.62%, with operating and profit margins of 1.8% and -4.94%.
Gross Margin | 34.62% |
Operating Margin | 1.8% |
Pretax Margin | -2.77% |
Profit Margin | -4.94% |
EBITDA Margin | 1.8% |
EBIT Margin | 1.8% |
FCF Margin | 5.23% |
Dividends & Yields
ICUI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -3.22% |
FCF Yield | 3.39% |
Analyst Forecast
The average price target for ICUI is $200, which is 33.4% higher than the current price. The consensus rating is "Buy".
Price Target | $200 |
Price Target Difference | 33.4% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Stock Splits
The last stock split was on Mar 18, 2002. It was a forward split with a ratio of 3:2.
Last Split Date | Mar 18, 2002 |
Split Type | forward |
Split Ratio | 3:2 |
Scores
Altman Z-Score | 2.07 |
Piotroski F-Score | 6 |